Oramed extends Scilex note repayment deadline to Sept. 30, 2026; bylaws amended
Oramed and Scilex Holding agreed on June 25, 2026 to a further extension of Scilex's payment obligations to Oramed under two senior notes. Scilex has paid $0.5 million so far, with $5 million due by July 31, 2026 and the remaining balance due by September 30, 2026. The filing also says Oramed's board approved amended bylaws effective June 25, 2026 that change stockholder written consent procedures.
Key points
- Scilex owed approximately $29.5 million under the Tranche A Note and $6.7 million under the Tranche B Note as of June 30, 2026.
- Oramed received $0.5 million from Scilex on June 25, 2026; $5 million is due on or before July 31, 2026, and the remaining balance on or before September 30, 2026.
- If Scilex does not pay in full by September 30, 2026, the first $1.5 million received would be treated as a non-refundable extension fee, and Scilex has agreed to settle the remaining amount with Scilex common stock.
- Fifth Amended and Restated Bylaws, effective June 25, 2026, revise record date procedures for written consent, eliminate a information requirement for record date requests, and set a 60-day delivery window for consents.
The filing
Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 30, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.